Ticker

Analyst Price Targets — COYA

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
June 5, 2026 8:18 amRoth Capital$12.00$4.87TheFly Coya Therapeutics initiated with a Buy at Roth Capital
November 5, 2025 1:48 pmLake Street$17.00$5.76TheFly Coya Therapeutics price target raised to $17 from $16 at Lake Street
September 16, 2024 9:27 amRaghuram SelvarajuH.C. Wainwright$18.00$6.12Benzinga This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday

Latest News for COYA

Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, announces that the Company will present an overview of the ongoing ALSTARS trial, outlining its design and approach to targeting neuroinflammation, at the European Network to…

Business Wire • Jun 18, 2026
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced it will host a live webinar on June 24, 2026 at 4 p.m. ET / 1 p.m. PT. Titled ‘Beyond the Hit: How Repetitive Head Trauma, Inflammation, and Neurodegenerative…

Business Wire • Jun 15, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for COYA.

No House trades found for COYA.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top